Delivery Order SPE2DB20D2104-SPE2DB24FT07S
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,400.26, is for the delivery of clonidine hydrochloride extended-release 0.1 mg tablets. The contract has an ultimate completion date of January 29, 2025 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Clonidine Hydrochloride Extended-Release 0.1 mg tablets. The contract is a Firm Fixed Price Delivery Order valued at $2,027.41, with an ultimate completion date of October 16, 2024. No set-aside designation was used for this award. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,127.80, is for the delivery of Clonidine Hydrochloride Extended Release 0.1 milligram tablets in 60-count packages. The contract is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,640.85, is for the delivery of clonidine hydrochloride extended-release 0.1 mg tablets. The contract is a firm fixed-price delivery order with a performance period ending on December 15, 2023. This contract award is not designated as a set-aside and appears to be part of a larger Indefinite...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,182.15, covers the delivery of Clonidine HCL ER 0.1 MG tablets to support military healthcare programs. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $3,082.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of CLONIDINE HCL ER 0.1 MG TABLET 60S, a generic pharmaceutical product. The contract has an ultimate completion date of October 28, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,810.82 firm fixed price delivery order is for the supply of 4564147411 - Clonidine HCL ER 0.1 mg Tablets, 60s. This award is a child order under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary...
- This federal contract award, valued at $2,137.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of clonidine hydrochloride extended-release 0.1 mg tablets in 60-count packages. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of Clonidine Hydrochloride Extended-Release 0.1 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type and a Ceiling Value of $22,348.87. The award date is September 16, 2024, and the ultimate completion date is September 17, 2024. This contract is not designated as a set-aside. As a large...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,900.30 firm fixed-price delivery order is for the supply of 4562815802 - Clonidine HCL ER 0.1 mg Tablets in 60-count packages. The contract has an ultimate completion date of November 15, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FT07SDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,839.20 Firm Fixed Price Delivery Order is for the supply of Clonidine Hydrochloride Extended Release 0.1 mg Tablets in 60-count packages. The award has an ultimate completion date of March 18, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Cencora, Inc. maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 3/15/24 |